Efficacy and safety of molnupiravir for COVID-19 patients
Author:
Publisher
Elsevier BV
Subject
Internal Medicine
Reference9 articles.
1. Molnupiravir and its antiviral activity against COVID-19;Tian;Front Immunol,2022
2. Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach;Dal-Ré;Lancet Infect Dis,2022
3. Discovery, development, and patent trends on molnupiravir: a prospective oral treatment for covid-19;Imran;Molecules,2021
4. Cochrane handbook for systematic reviews of interventions,2019
5. Randomized trial of molnupiravir or placebo in patients hospitalized with Covid-19;Arribas;NEJM Evid,2022
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy of COVID-19 Oral antivirals in hospitalised oldest-old with high morbidity burden: a target trial emulation study;Age and Ageing;2024-08
2. Molnupiravir for the treatment of COVID-19 outpatients: An updated meta-analysis;Journal of Microbiology, Immunology and Infection;2024-06
3. Colchicine for the treatment of patients with COVID-19: an updated systematic review and meta-analysis of randomised controlled trials;BMJ Open;2024-04
4. In reply to comment on: Association between high-dose molnupiravir and COVID-19 mortality rate;International Journal of Antimicrobial Agents;2024-03
5. Nigella sativa for the treatment of COVID‐19 patients: A rapid systematic review and meta‐analysis of randomized controlled trials;Food Science & Nutrition;2023-12-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3